Νευρολογία

Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients With Chronic Migraine Attacks in Greece

Authors: Theodoros V Giannouchos, Dimos-Dimitrios Mitsikostas, Robert L Ohsfeldt, Athanassios Vozikis, Paraskevi Koufopoulou  Background: Migraine is a common, chronic neurovascular brain disorder with non-negligible multifaceted economic costs. Existing preventive treatments involve the selective use of onabotulinumtoxinA, which aims at migraine morbidity reduction for patients who have failed initial preventive treatment with oral agents. Erenumab is a new preventive treatment for…

Postnatal Innate Immune Development: From Birth to Adulthood

Abstract It is well established that adaptive immune responses are deficient in early life, contributing to increased mortality and morbidity. The developmental trajectories of different components of innate immunity are only recently being explored. Individual molecules, cells, or pathways of innate recognition and signaling, within different compartments/anatomical sites, demonstrate variable maturation patterns. Despite some discrepancies…

ΥΠΕΡΗΧΟΓΡΑΦΙΚΗ ΔΙΑΓΝΩΣΗ ΤΗΣ ΩΛΕΝΙΑΣ ΝΕΥΡΟΠΑΘΕΙΑΣ ΣΤΟΝ ΑΓΚΩΝΑ

72ο Συνεδριο Ορθοπαιδικης 2016(1).1